INMED PHARMACEUTICALS INC. Repayments of Debt
INMED PHARMACEUTICALS INC. (INM) reported Repayments of Debt of $290.83 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2023-09-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2023-09-29
- INMED PHARMACEUTICALS INC. repayments of debt for the quarter ending 2022-06-30 was $29.31K.
- INMED PHARMACEUTICALS INC. repayments of debt for the quarter ending 2022-03-31 was $29.31K.
- INMED PHARMACEUTICALS INC. repayments of debt for fiscal 2022 was $290.83K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2022-06-30 | $29.31K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-29 | $58.62K derived: sum of 2 quarters · filed 2023-09-29 | $290.83K 10-K · filed 2023-09-29 | |
| 2022-03-31 | $29.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $261.51K 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | $232.20K 10-Q · filed 2023-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |